Pfizer Limited share price
NSE: PFIZER · ISIN INE182A01018
Key numbers
- Market cap
- ₹ 18,303 Cr
- Current price
- ₹ 4,000.80
- 52-week high / low
- ₹ 5,579 / 3,956
- Stock P/E
- 24.9
- Book value
- ₹ 918.7
- Dividend yield
- 1.87%
- ROCE
- 22.9%
- ROE
- 17.2%
- Debt to equity
- 0.02
- Sales growth (3 yrs)
- 1.3%
- Profit growth (3 yrs)
- 5.0%
- 1-year return
- -20.4%
About Pfizer Limited
Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers therapy area and products, such as vaccines, injectables and anti-infectives, inflammation and immunology, and internal medicine for cardiovascular care, oncology, respiratory, multivitamins and multimineral, neuroscience, women's health, gastroenterology, pain management, and nutrition, addressing. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a network of independent distributors. Pfizer Limited was incorporated in 1950 and is based in Mumbai, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 603 | 642 | 645 | 629 | 653 |
| Operating profit | 210 | 230 | 228 | 236 | 248 |
| Net profit | 192 | 189 | 142 | 200 | 204 |
| EPS (₹) | 41.91 | 41.32 | 31.01 | 43.68 | 44.69 |
Peers in Drug Manufacturers - General
Data for information only, not investment advice. Prices end of day.